Safety and feasibility of complete simultaneous revascularization during primary PCI in patients with STEMI and multi-vessel disease

Egyptian Heart Journal

Volumn 63, Issue 1, 2011, Pages 39-43

  Maamoun, Walid ^a   Elkhaeat, Nabil ^b   Elarasy, Rasha ^b  

^a AIN SHAMS UNIVERSITY   (Egypt)

^b UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Yemen)

Author keywords

Acute STEMI; Multi vessel disease; Primary PCI

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; GLYCERYL TRINITRATE; HEPARIN;

ADULT; ANGINA PECTORIS; ANGIOCARDIOGRAPHY; ANGIOGRAPHY; ANGIOPLASTY; ARTICLE; CEREBROVASCULAR DISEASE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DEATH; FEMALE; FOLLOW UP; HEART INFARCTION; HOSPITAL READMISSION; HUMAN; ISCHEMIA; MAJOR CLINICAL STUDY; MALE; MULTI VESSEL DISEASE; PERCUTANEOUS CORONARY INTERVENTION; RECURRENT DISEASE; REVASCULARIZATION; RISK ASSESSMENT; ST SEGMENT ELEVATION; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; TREATMENT OUTCOME; VASCULAR DISEASE;

EID: 84879194006     PISSN: 11102608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ehj.2011.08.030     Document Type: Article

References (21)

1. Muller D.W., Topol E.J., Ellis S.G., et al. Multivessel coronary artery disease a key predictor of short-term prognosis after reperfusion therapy for acute myocardial infarction Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) Study Group. Am Heart J 1991, 121(4 Pt 1):1042-1049.
2. Jaski B.E., Cohen J.D., Trausch J., et al. Outcome of urgent percutaneous transluminal coronary angioplasty in acute myocardial infarction: comparison of single-vessel versus multivessel coronary artery disease. Am Heart J 1992, 124(6):1427-1433.
3. Sanz G., Castaner A., Betriu A., et al. Determinants of prognosis in survivors of myocardial infarction: a prospective clinical angiographic study. N Engl J Med 1982, 306:1065-1070.
4. Webb J.G., Lowe A.M., Sanborn T.A., et al. Percutaneous coronary intervention for cardiogenic shock in the SHOCK trial. J Am Coll Cardiol 2003, 42(8):1380-1386.
5. Smith S.C., Feldman T.E., Hirshfeld J.W., et al. ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention - Summary article a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention). Circulation 2006, 113(1):156-175.
6. Roe M.T., Cura F.A., Joski P.S., et al. Initial experience with multivessel percutaneous coronary intervention during mechanical reperfusion for acute myocardial infarction. Am J Cardiol 2001, 88(2):170-173. A6.
7. Di Mario C., Mara S., Flavio A., Imad S., Antonio M., Anna P., et al. Single vs multivessel treatment during primary angioplasty results of the multicentre randomized HEpacoat for cuLPrit or multivessel stenting for Acute Myocardial Infarction (HELP AMI) Study. Int J Cardiovasc Intervent 2004, 6(3-4):128-133.
8. Sorajja P., Gersh B.J., Cox D.A., et al. Impact of multi vessel disease on reperfusion success and clinical outcomes in patients undergoing primary percutaneous coronary interventions for acute myocardial infarction. Eur Heart J 2007, 28:1709-1716.
9. Hannan E.L., Racz M.J., McCallister B.D., et al. A comparison of three-year survival after coronary artery bypass graft surgery and percutaneous transluminal coronary angioplasty. J Am Coll Cardiol 1999, 33:63-72.
10. Mauri L., Silbaugh T.S., Garg P., et al. Drug-eluting or bare-metal stents for acute myocardial infarction. N Engl J Med 2008, 359:1330-1342.
11. Kastrati A., Dibra A., Spaulding C., et al. Meta-analysis of randomized trials on drug-eluting stents vs bare-metal stents in patients with acute myocardial infarction. Eur Heart J 2007, 28:2706-2713.
12. De Luca G., Stone G., Suryapranata H., et al. Efficacy and safety of drug-eluting stents in ST-segment elevation myocardial infarction meta-analysis of randomized trials. Int J Cardiol 2009, 133:213-222.
13. Corpus R.A., House J.A., Marso S.P., et al. Multivessel percutaneous coronary intervention in patients with multivessel disease and acute myocardial infarction. Am Heart J 2004, 148:493-500.
14. Politi L., Sgura F., Rossi R., et al. Multivessel coronary disease in ST-elevation myocardial infarction three different revascularization strategies and long-term outcomes. Heart 2009, [E-pub ahead of print].
15. Cavender M., Milford-Beland S., Roe M., et al. Prevalence predictors and in-hospital outcomes of non-infarct artery intervention during primary percutaneous intervention for ST-segment elevation myocardial infarction (from the National Cardiovascular Data Registry). Am J Cardiol 2009, 104:507-513.
16. Moussa I., Riemers B., Moses J., et al. Long-term angiographic and clinical outcome of patients undergoing multivessel coronary stenting. Circulation 1997, 96:3873-3879.
17. Han Ya-ling, Wang Bin, Wang Xiao-zeng, et al. Comparative effects of percutaneous coronary intervention for infarct-related artery only or for both infarct- and non-infarctrelated arteries in patients with ST-elevation myocardial infarction and multi-vessel disease. Chin Med J 2008, 121(23):2384-2387.
18. Khattab A.A., Abdel-Wahab M., Rther C, et al. Multi-vessel stenting during primary percutaneous coronary intervention for acute myocardial infarction. A single-center experience. Clin Res Cardiol 2008, 97:32-38.
19. Hannan E., Samadashvili Z., Walford G., et al. Culprit vessel percutaneous coronary intervention versus multivessel and staged percutaneous coronary intervention for ST-segment elevation myocardial infarction patients with multivessel disease. JACC Cardiovasc Interv 2010, 3(1):22-31.
20. Qarawani D., Nahir M., Abboud M., et al. Culprit only versus complete coronary revascularization during primary PCI. Int J Cardiol 2008, 123(3):288-292.
21. Telayna J.M., Lev G.A., Valdivieso L., et al. Percutaneous interventional approach in acute myocardial infarction treatment of culprit lesion versus complete revascularization. Am J Card 2002, 47-48H.